Founded by a group of individuals from Harvard, including renowned geneticist George Church, Nebula Genomics aims to create a trusted marketplace for genomic and health data. By leveraging blockchain, individuals can maintain control over their data and be compensated for its use. Researchers can access this aggregated genetic information to accelerate drug development, streamline clinical trials, and advance personalized medicine. Nebula Genomics is backed by prominent investors and provides customized reports on genetic variants, risk scores, and research findings.